IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β and tumor necrosis factor-α-induced κB-dependent transcription -: Requirement for an additional activation pathway

被引:171
作者
Bergmann, M [1 ]
Hart, L [1 ]
Lindsay, M [1 ]
Barnes, PJ [1 ]
Newton, R [1 ]
机构
[1] Imperial Coll, Sch Med, Natl Heart & Lung Inst, Dept Thorac Med, London SW3 6LY, England
关键词
D O I
10.1074/jbc.273.12.6607
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two closely related I kappa B alpha kinases as well as the upstream kinase, NIK, which integrates interleukin-1 beta (IL-1 beta)- and tumor necrosis factor (TNF)-alpha-dependent activation of the transcription factor NF-kappa B have recently been described. However, in this emerging pathway the role of previously identified components of cytokine-induced NF-kappa B activation, namely phosphatidylcholine-specific phospholipase C and protein kinase C, remains unclear, We now show that, in A549 human alveolar epithelial cells, the activation of a stably transfected NF-kappa B dependent reporter gene by TNF-alpha and IL-1 beta is completely blocked by the phosphatidylcholine-specific phospholipase C inhibitor D609 and the protein kinase C inhibitor RO31-8220. However, IL-1 beta-induced I kappa B alpha degradation as well as NF-kappa B nuclear translocation and DNA binding, as determined by Western blot and electro-mobility shift assay, respectively, are not affected by these inhibitors, A similar effect, although less pronounced, is observed with the p38 mitogen-activated protein kinase inhibitor SE 203580. On the basis of these data we propose the existence of a second signaling pathway induced by IL-1 beta and TNF-alpha that is activated in parallel to the cascade leading to I kappa B alpha degradation and is specifically required for NF-kappa B-dependent transcriptional competency.
引用
收藏
页码:6607 / 6610
页数:4
相关论文
共 38 条
[1]   The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1 beta (Rsk-2) and p70 S6 kinase [J].
Alessi, DR .
FEBS LETTERS, 1997, 402 (2-3) :121-123
[2]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[3]   The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor [J].
Beyaert, R ;
Cuenda, A ;
VandenBerghe, W ;
Plaisance, S ;
Lee, JC ;
Haegeman, G ;
Cohen, P ;
Fiers, W .
EMBO JOURNAL, 1996, 15 (08) :1914-1923
[4]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[5]   A DOMINANT-NEGATIVE PROTEIN-KINASE-C ZETA-SUBSPECIES BLOCKS NF-KAPPA-B ACTIVATION [J].
DIAZMECO, MT ;
BERRA, E ;
MUNICIO, MM ;
SANZ, L ;
LOZANO, J ;
DOMINGUEZ, I ;
DIAZGOLPE, V ;
DELERA, MTL ;
ALCAMI, J ;
PAYA, CV ;
ARENZANASEISDEDOS, F ;
VIRELIZIER, JL ;
MOSCAT, J .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (08) :4770-4775
[6]   A cytokine-responsive IκB kinase that activates the transcription factor NF-κB [J].
Joseph A. DiDonato ;
Makio Hayakawa ;
David M. Rothwarf ;
Ebrahim Zandi ;
Michael Karin .
Nature, 1997, 388 (6642) :548-554
[7]   A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE [J].
DUDLEY, DT ;
PANG, L ;
DECKER, SJ ;
BRIDGES, AJ ;
SALTIEL, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7686-7689
[8]   ANALYSIS OF THE ROLE OF PROTEIN-KINASE-C-ALPHA, PROTEIN-KINASE-EPSILON, AND PROTEIN-KINASE-ZETA IN T-CELL ACTIVATION [J].
GENOT, EM ;
PARKER, PJ ;
CANTRELL, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (17) :9833-9839
[9]  
HAYASHI T, 1993, J BIOL CHEM, V268, P26790
[10]   THE PROTEIN-TYROSINE KINASE FYN ACTIVATES TRANSCRIPTION FROM THE HIV PROMOTER VIA ACTIVATION OF NF-KAPPA-B-LIKE DNA-BINDING PROTEINS [J].
HOHASHI, N ;
HAYASHI, T ;
FUSAKI, N ;
TAKEUCHI, M ;
HIGURASHI, M ;
OKAMOTO, T ;
SEMBA, K ;
YAMAMOTO, T .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (11) :1851-1859